Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04172675
Title A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Janssen Research & Development, LLC
Indications

non-invasive bladder urothelial carcinoma

Therapies

Erdafitinib

Gemcitabine

Mitomycin C

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST